126 related articles for article (PubMed ID: 7685960)
1. Tenascin in inflammatory conditions and neoplasms of the urinary bladder.
Tiitta O; Wahlström T; Virtanen I; Gould VE
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(5):283-7. PubMed ID: 7685960
[TBL] [Abstract][Full Text] [Related]
2. Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma.
Tiitta O; Happonen RP; Virtanen I; Luomanen M
J Oral Pathol Med; 1994 Nov; 23(10):446-50. PubMed ID: 7532219
[TBL] [Abstract][Full Text] [Related]
3. Tenascin expression in inflammatory, dysplastic and neoplastic lesions of the human stomach.
Tiitta O; Sipponen P; Gould V; Virtanen I
Virchows Arch; 1994; 425(4):369-74. PubMed ID: 7529617
[TBL] [Abstract][Full Text] [Related]
4. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
[TBL] [Abstract][Full Text] [Related]
5. Enhanced tenascin expression in cervical and vulvar koilocytotic lesions.
Tiitta O; Wahlström T; Paavonen J; Linnala A; Sharma S; Gould VE; Virtanen I
Am J Pathol; 1992 Oct; 141(4):907-13. PubMed ID: 1384340
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder.
Berndt A; Anger K; Richter P; Borsi L; Brack S; Silacci M; Franz M; Wunderlich H; Gajda M; Zardi L; Neri D; Kosmehl H
J Cancer Res Clin Oncol; 2006 Aug; 132(8):537-46. PubMed ID: 16788848
[TBL] [Abstract][Full Text] [Related]
7. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.
Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE
J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813
[TBL] [Abstract][Full Text] [Related]
8. Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder.
Booth C; Harnden P; Selby PJ; Southgate J
J Pathol; 2002 Nov; 198(3):359-68. PubMed ID: 12375269
[TBL] [Abstract][Full Text] [Related]
9. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA
Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973
[TBL] [Abstract][Full Text] [Related]
10. Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder.
Chang S; Lee S; Lee C; Kim JI; Kim Y
Urology; 2000 Mar; 55(3):448-52. PubMed ID: 10699635
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tenascin immunoreactivity in leukoplakia and squamous cell carcinoma of the oral cavity: an immunohistochemical study.
Shrestha P; Sakamoto F; Takagi H; Yamada T; Mori M
Eur J Cancer B Oral Oncol; 1994; 30B(2):132-7. PubMed ID: 7518275
[TBL] [Abstract][Full Text] [Related]
12. Basement membrane and extracellular interstitial matrix components in bladder neoplasia--evidence of angiogenesis.
Deen S; Ball RY
Histopathology; 1994 Nov; 25(5):475-81. PubMed ID: 7532615
[TBL] [Abstract][Full Text] [Related]
13. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma.
Vinall RL; Kent MS; deVere White RW
Am J Vet Res; 2012 Oct; 73(10):1626-33. PubMed ID: 23013190
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast.
Gould VE; Koukoulis GK; Virtanen I
Cell Differ Dev; 1990 Dec; 32(3):409-16. PubMed ID: 1711920
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues.
Natali PG; Nicotra MR; Bigotti A; Botti C; Castellani P; Risso AM; Zardi L
Int J Cancer; 1991 Apr; 47(6):811-6. PubMed ID: 1707033
[TBL] [Abstract][Full Text] [Related]
16. Tenascin expression in astrocytomas correlates with angiogenesis.
Zagzag D; Friedlander DR; Miller DC; Dosik J; Cangiarella J; Kostianovsky M; Cohen H; Grumet M; Greco MA
Cancer Res; 1995 Feb; 55(4):907-14. PubMed ID: 7531617
[TBL] [Abstract][Full Text] [Related]
17. Localization of tenascin in uterine sarcomas and partially transformed endometrial stromal cells.
Vollmer G; Lightner VA; Carter CA; Siegal GP; Erickson HP; Knuppen R; Kaufman DG
Pathobiology; 1993; 61(2):67-76. PubMed ID: 7692874
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer.
Moch H; Torhorst J; Dürmüller U; Feichter GE; Sauter G; Gudat F
Pathol Res Pract; 1993 Jun; 189(5):510-4. PubMed ID: 7690952
[TBL] [Abstract][Full Text] [Related]
19. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
20. [Expression of extracellular matrix (tenascin) in the gastric cancer--an immunohistochemical study].
Yano S
Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1085-91. PubMed ID: 7694065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
